LLY
Eli Lilly and Company
Revenue by region
2025, ended Dec 31, 2025
Earlier:
Regions by fiscal year
| USDLine, in USD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 43.5B | 30.4B | 21.8B | 18.2B | 16.8B | 14.2B | 12.7B | 12.4B | 11.4B | 11.5B | 10.1B | 9.1B | 12.9B | 12.3B | 13.0B | 12.9B |
| Outside U.S. | 21.7B | 14.7B | 12.3B | 10.4B | 11.5B | 10.3B | 9.6B | 9.1B | 8.6B | 9.7B | — | — | — | — | — | — |
Europe | 11.6B | 6.9B | 6.2B | 4.3B | 4.8B | 4.2B | 3.8B | 3.7B | 3.4B | 3.8B | 3.9B | 4.5B | 4.3B | 4.3B | 5.3B | 5.1B |
Rest of world | 6.06B | 4.27B | 2.95B | 2.85B | — | — | — | — | — | — | — | — | — | — | — | — |
China | 1.95B | 1.66B | 1.54B | 1.45B | 1.66B | 1.12B | 0.94B | 0.75B | — | — | — | — | — | — | — | — |
Japan | 2.13B | 1.82B | 1.67B | 1.75B | 2.37B | 2.58B | 2.55B | 2.41B | 2.34B | 2.33B | 2.03B | 2.03B | 2.06B | 2.25B | 2.10B | 1.62B |
Other foreign countries | — | — | — | — | 2.70B | 2.42B | 2.34B | 2.28B | 2.83B | 3.62B | 3.88B | 3.95B | 3.82B | 3.78B | 3.91B | 3.49B |
| Total | 65.2B | 45.0B | 34.1B | 28.5B | 28.3B | 24.5B | 22.3B | 21.5B | 20.0B | 21.2B | 20.0B | 19.6B | 23.1B | 22.6B | 24.3B | 23.1B |